ArticleJournal of thrombosis and thrombolysis2020

The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding.

Sarah Hanigan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.